While touting the Philippine pharmaceutical industry as one of the strongest in Southeast Asia, a study commissioned by the Pharmaceutical & Healthcare Association of the Philippines (PHAP) has also acknowledged the challenges it continues to face due to the prevalence of communicable and non-communicable diseases, as well as the devastating effects left by mega-disasters that struck in 2013.
Significant steps have already been accomplished by the pharmaceutical industry to address these challenges, and ongoing efforts are being made to further increase patient access to quality medication and healthcare.
.jpg)
